In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘LungCancer’ clear

  • A Maine man diagnosed with late-stage lung cancer six months ago is now effectively cancer-free following an experimental treatment at Dana-Farber.

Tags: BasicResearch, LungCancer

  • A government panel recommended heavy smokers over 55 have a CT scan to check for lung cancer. Dr. Christopher Lathan says this is a tremendous opportunity to really change the tide in lung cancer treatment.

Tags: BasicResearch, LungCancer

  • Dr. Pasi Janne is leading a study on a new lung cancer treatment that targets tumors in patients with a genetic mutation.


Tags: LungCancer

  • Dr. Deborah Schrag reported in the Journal of the American Medical Association that non-small cell lung cancer patients 65 years of age and older did not receive any survival benefit when Avastin was added to their standard chemotherapy. This finding counters an earlier study.

Tags: LungCancer

  • Dr. Bruce Johnson talks about new treatments and better targeted therapies for small-cell lung cancer.

Tags: LungCancer

  • Dr. Edward J. Benz, Jr. advocated for bolder federal action against tobacco sales.

Tags: LungCancer, Smoking

  • Researchers, including Dr. Matthew Meyerson and Dr. Bruce Johnson of Dana-Farber, found from a large study of the genetics of a common lung cancer, that more than half the tumors from that cancer have mutations that can be treated by drugs that are being developed or can be easily developed. (Full article requires a subscription)

Tags: BasicResearch, LungCancer, Genetics

  • Genetic testing can help clinicians assess a patient's risk for various diseases and to develop more effective treatment plans. Dana-Farber currently offers lung cancer patients six genetic tests and soon will test for more than 500 cancer-causing gene defects. As more genetic tests become available, some insurers and medical ethicists are questioning the value of such tests.

Tags: LungCancer, Genetics

  • Dr. Kwok-Kin Wong commented on the use of EZH2 inhibitors in lung cancer as needing more rationale in preclinical studies.

Tags: LungCancer

  • A study led by Dr. Christopher Lathan shows that cancer patients with limited finances are more likely to have increased symptoms and poorer quality of life.

Tags: ColonCancer, LungCancer

Showing 1-10 of 27 items